Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

tonabersat

Known as: 6-acetyl-4-(3-chloro-4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo(b)pyran-3-ol, N-((3S,4S)-6-Acetyl-3-hydroxy-2,2-dimethylchroman-4-yl)-3-chloro-4-fluorobenzamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Increased Connexin43 hemichannel opening is associated with inflammasome pathway activation and inflammation in a range of… 
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 6
2017
2017
The cis benzopyran compound tonabersat (SB-220453) has previously been reported to inhibit connexin26 expression in the brain by… 
  • figure 2
  • figure 4
  • figure 5
Highly Cited
2009
Highly Cited
2009
Tonabersat is a novel putative migraine prophylactic agent with an unique stereospecific binding site in the brain. Tonabersat… 
  • figure 1
  • figure 2
  • table 1
Highly Cited
2009
Highly Cited
2009
Background.— Sensitization and activation of trigeminal neurons are implicated in the underlying pathology of migraine, acute… 
2009
2009
Tonabersat is a novel benzopyran derivative that blocks the cortical spreading depression proposed to be associated with migraine… 
  • table 1
  • table 2
  • figure 1
  • table 4
  • table 5
2009
2009
The ability of tonabersat to relieve the symptoms of migraine attacks with or without aura was evaluated in a randomized, double… 
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
2001
2001
The effects of tonabersat (SB‐220453) were evaluated on trigeminal nerve ganglion stimulation‐induced sensory‐autonomic… 
2001
2001
Spreading cortical depolarization and depression of electroencephalographic activity (SD) may underlie the aura and spreading…